Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 20, 2005
Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany
Uwe Siebert, Gaby Sroczynski, Jürgen Wasem, et al.
BMC Health Services Research
|
February 11, 2018
Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany
Ana Babac, Martin Frank, Frédéric Pauer, et al.
BMC Family Practice
|
November 21, 2020
Evaluation of two family-based intervention programs for children affected by rare disease and their families - research network (CARE-FAM-NET): study protocol for a rater-blinded, randomized, controlled, multicenter trial in a 2x2 factorial design
Johannes Boettcher, Bonnie Filter, Jonas Denecke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 16, 2008
German recommendations on health economic evaluation: third and updated version of the Hanover Consensus
J-Matthias Graf von der Schulenburg, Wolfgang Greiner, Fred Jost, et al.
The European Respiratory Journal
|
June 16, 2012
Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial
Martine Hoogendoorn, Maiwenn J Al, Kai-Michael Beeh, et al.
Interactive Journal of Medical Research
|
August 27, 2016
Adopting Quality Criteria for Websites Providing Medical Information About Rare Diseases
Frédéric Pauer, Jens Göbel, Holger Storf, et al.
JMIR Research Protocols
|
May 13, 2018
Conceptualization and Implementation of the Central Information Portal on Rare Diseases: Protocol for a Qualitative Study
Svenja Litzkendorf, Tobias Hartz, Jens Göbel, et al.
BMJ Open Sport & Exercise Medicine
|
October 17, 2022
Impact of electrically assisted bicycles on physical activity and traffic accident risk: a prospective observational study
Sven Haufe, Hedwig Theda Boeck, Sebastian Häckl, et al.
JMIR Research Protocols
|
September 22, 2018
Metadata Correction: Conceptualization and Implementation of the Central Information Portal on Rare Diseases: Protocol for a Qualitative Study
Svenja Litzkendorf, Tobias Hartz, Jens Göbel, et al.
Orphanet Journal of Rare Diseases
|
February 7, 2024
Real-world evidence for coverage determination of treatments for rare diseases
Victoria W Dayer, Michael F Drummond, Omar Dabbous, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
May 20, 2005
Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany
Uwe Siebert, Gaby Sroczynski, Jürgen Wasem, et al.
BMC Health Services Research
|
February 11, 2018
Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany
Ana Babac, Martin Frank, Frédéric Pauer, et al.
BMC Family Practice
|
November 21, 2020
Evaluation of two family-based intervention programs for children affected by rare disease and their families - research network (CARE-FAM-NET): study protocol for a rater-blinded, randomized, controlled, multicenter trial in a 2x2 factorial design
Johannes Boettcher, Bonnie Filter, Jonas Denecke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 16, 2008
German recommendations on health economic evaluation: third and updated version of the Hanover Consensus
J-Matthias Graf von der Schulenburg, Wolfgang Greiner, Fred Jost, et al.
The European Respiratory Journal
|
June 16, 2012
Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial
Martine Hoogendoorn, Maiwenn J Al, Kai-Michael Beeh, et al.
Interactive Journal of Medical Research
|
August 27, 2016
Adopting Quality Criteria for Websites Providing Medical Information About Rare Diseases
Frédéric Pauer, Jens Göbel, Holger Storf, et al.
JMIR Research Protocols
|
May 13, 2018
Conceptualization and Implementation of the Central Information Portal on Rare Diseases: Protocol for a Qualitative Study
Svenja Litzkendorf, Tobias Hartz, Jens Göbel, et al.
BMJ Open Sport & Exercise Medicine
|
October 17, 2022
Impact of electrically assisted bicycles on physical activity and traffic accident risk: a prospective observational study
Sven Haufe, Hedwig Theda Boeck, Sebastian Häckl, et al.
JMIR Research Protocols
|
September 22, 2018
Metadata Correction: Conceptualization and Implementation of the Central Information Portal on Rare Diseases: Protocol for a Qualitative Study
Svenja Litzkendorf, Tobias Hartz, Jens Göbel, et al.
Orphanet Journal of Rare Diseases
|
February 7, 2024
Real-world evidence for coverage determination of treatments for rare diseases
Victoria W Dayer, Michael F Drummond, Omar Dabbous, et al.
Page
of 11